SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025
SI-BONE (Nasdaq: SIBN), a medical device company focused on sacropelvic disorders, announced its participation in the Goldman Sachs 46th Global Healthcare Conference in Miami Beach. The company's management will conduct a fireside chat on June 10, 2025, at 8:20 AM PT/11:20 AM ET. Investors can access the live webcast through registration and the company's website. The webcast recording will be available for replay on SI-BONE's investor relations page for at least 90 days following the event.
SI-BONE (Nasdaq: SIBN), un'azienda di dispositivi medici specializzata in disturbi sacropelvici, ha annunciato la sua partecipazione alla 46ª Conferenza Globale sulla Sanità di Goldman Sachs a Miami Beach. Il management dell'azienda terrà una chiacchierata informale il 10 giugno 2025, alle 8:20 AM PT/11:20 AM ET. Gli investitori potranno seguire la diretta streaming previa registrazione sul sito web dell'azienda. La registrazione del webcast sarà disponibile per la visione in differita sulla pagina delle relazioni con gli investitori di SI-BONE per almeno 90 giorni dopo l'evento.
SI-BONE (Nasdaq: SIBN), una empresa de dispositivos médicos enfocada en trastornos sacropélvicos, anunció su participación en la 46ª Conferencia Global de Salud de Goldman Sachs en Miami Beach. La dirección de la compañía realizará una charla informal el 10 de junio de 2025, a las 8:20 AM PT/11:20 AM ET. Los inversionistas podrán acceder a la transmisión en vivo mediante registro y a través del sitio web de la empresa. La grabación estará disponible para reproducción en la página de relaciones con inversionistas de SI-BONE durante al menos 90 días después del evento.
SI-BONE (나스닥: SIBN), 천장골 질환에 집중하는 의료기기 회사가 마이애미 비치에서 열리는 골드만삭스 제46회 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 2025년 6월 10일 오전 8:20 PT/오전 11:20 ET에 파이어사이드 채팅을 진행할 예정입니다. 투자자들은 등록을 통해 회사 웹사이트에서 라이브 웹캐스트를 시청할 수 있습니다. 웹캐스트 녹화 영상은 행사 후 최소 90일간 SI-BONE 투자자 관계 페이지에서 다시보기로 제공됩니다.
SI-BONE (Nasdaq : SIBN), une entreprise de dispositifs médicaux spécialisée dans les troubles sacropelviens, a annoncé sa participation à la 46e conférence mondiale sur la santé de Goldman Sachs à Miami Beach. La direction de la société tiendra une discussion informelle le 10 juin 2025 à 8h20 PT/11h20 ET. Les investisseurs pourront accéder à la diffusion en direct en s'inscrivant via le site internet de l'entreprise. L'enregistrement du webcast sera disponible en replay sur la page des relations investisseurs de SI-BONE pendant au moins 90 jours après l'événement.
SI-BONE (Nasdaq: SIBN), ein Medizintechnikunternehmen, das sich auf sakropelvine Erkrankungen spezialisiert hat, gab seine Teilnahme an der 46. Global Healthcare Conference von Goldman Sachs in Miami Beach bekannt. Das Management des Unternehmens wird am 10. Juni 2025 um 8:20 Uhr PT/11:20 Uhr ET ein Gespräch am Kamin führen. Investoren können über eine Registrierung und die Webseite des Unternehmens auf das Live-Webcast zugreifen. Die Aufzeichnung des Webcasts wird für mindestens 90 Tage nach der Veranstaltung auf der Investor-Relations-Seite von SI-BONE zum Abruf bereitstehen.
- None.
- None.
SANTA CLARA, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 Goldman Sachs 46th Global Healthcare Conference in Miami Beach, FL. Management will be hosting a fireside chat on Tuesday, June 10, 2025, at 8:20 a.m. Pacific Time/11:20 a.m. Eastern Time.
Investors interested in listening to the conference call may do so by registering at this link: Glodman Sachs 46th Healthcare Conference. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.
About SI-BONE, Inc.
SI-BONE (NASDAQ: SIBN) is a global leader in developing unique technologies for surgical treatment of sacropelvic disorders. Since pioneering minimally invasive SI joint surgery in 2009 with the iFuse Implant System®, SI-BONE has supported over 4,500 physicians in performing a total of over 120,000 procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies with over 160 peer reviewed publications including two randomized controlled trials. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic and sacropelvic fixation and pelvic trauma.
For additional information on the company or the products, including risks and benefits, please visit www.si-bone.com.
SI-BONE, Sacropelvic Solutions, iFuse Implant System®, iFuse Bedrock Granite, and iFuse TORQ, are registered trademarks, and iFuse 3D, iFuse TORQ TNT, and iFuse INTRA are trademarks of SI-BONE, Inc. ©2025 SI-BONE, Inc. All Rights Reserved.
Investor Contact: Saqib Iqbal, investors@si-bone.com
FAQ
When is SI-BONE (SIBN) presenting at the Goldman Sachs Healthcare Conference 2025?
How can investors access SI-BONE's (SIBN) presentation at the Goldman Sachs Conference?
How long will SI-BONE's (SIBN) Goldman Sachs Conference webcast be available for replay?
What type of presentation will SI-BONE (SIBN) give at the Goldman Sachs Healthcare Conference?
